董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| David M. Cordani | 男 | Chairman and Chief Executive Officer | 58 | 2096.55万美元 | 123.88 | 2024-02-29 |
| Elder Granger | 男 | Director | 70 | 38.29万美元 | 0.39 | 2024-02-29 |
| Kathleen M. Mazzarella | 女 | Director | 64 | 38.29万美元 | 0.49 | 2024-02-29 |
| Mark B. McClellan | 男 | Director | 60 | 35.79万美元 | 0.49 | 2024-02-29 |
| Kimberly A. Ross | 女 | Director | 59 | 38.54万美元 | 0.33 | 2024-02-29 |
| Neesha Hathi | 女 | Director | 50 | 35.79万美元 | 0.22 | 2024-02-29 |
| Philip Ozuah | 男 | Director | 61 | 未披露 | 0.06 | 2024-02-29 |
| Eric C. Wiseman | 男 | Director | 68 | 41.41万美元 | 0.42 | 2024-02-29 |
| Donna F. Zarcone | 女 | Director | 67 | 38.54万美元 | 1.43 | 2024-02-29 |
| Eric J. Foss | 男 | Director | 65 | 37.66万美元 | 3.47 | 2024-02-29 |
| William J. DeLaney | 男 | Director | 68 | 35.79万美元 | 2.31 | 2024-02-29 |
| George Kurian | 男 | Director | 57 | 35.79万美元 | 0.26 | 2024-02-29 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| David M. Cordani | 男 | Chairman and Chief Executive Officer | 58 | 2096.55万美元 | 123.88 | 2024-02-29 |
| Michael Triplett | -- | Special Advisor | 62 | 未披露 | 未持股 | 2024-02-29 |
| Brian C. Evanko | -- | Executive Vice President, Chief Financial Officer | 47 | 696.57万美元 | 12.40 | 2024-02-29 |
| Eric P. Palmer | -- | Executive Vice President, Enterprise Strategy | 47 | 856.28万美元 | 18.20 | 2024-02-29 |
| Noelle K. Eder | 女 | Executive Vice President, Global Chief Information Officer | 54 | 462.50万美元 | 5.57 | 2024-02-29 |
| David Brailer | -- | Executive Vice President and Chief Health Officer | 64 | 未披露 | 未持股 | 2024-02-29 |
| Mary T. Agoglia Hoeltzel | -- | Senior Vice President, Tax and Chief Accounting Officer | -- | 未披露 | 未持股 | 2024-02-29 |
| Nicole S. Jones | -- | Executive Vice President, Chief Administrative Officer and General Counsel | 53 | 523.27万美元 | 13.27 | 2024-02-29 |
董事简历
中英对照 | 中文 | 英文- David M. Cordani
-
David M. Cordani，2008年6月任公司总裁，2009年12月任首席执行官。2008年6月至2009年12月任首席运营官；2005年至2008年任Cigna HealthCare公司总裁；2004年至2005年任Cigna HealthCare公司客户及营销部门高级副总裁；1991年加入Cigna公司。他现任董事任期为2013年至2016年。
David M. Cordani,Chairman of the Board of The Cigna Group beginning January 2022; Chief Executive Officer beginning December 2009; Director since October 2009; President beginning June 2008; and Chief Operating Officer from June 2008 until December 2009. - David M. Cordani，2008年6月任公司总裁，2009年12月任首席执行官。2008年6月至2009年12月任首席运营官；2005年至2008年任Cigna HealthCare公司总裁；2004年至2005年任Cigna HealthCare公司客户及营销部门高级副总裁；1991年加入Cigna公司。他现任董事任期为2013年至2016年。
- David M. Cordani,Chairman of the Board of The Cigna Group beginning January 2022; Chief Executive Officer beginning December 2009; Director since October 2009; President beginning June 2008; and Chief Operating Officer from June 2008 until December 2009.
- Elder Granger
-
Elder Granger于2014年11月当选为董事会成员。Granger博士是退休的美国陆军少将，以及5Ps LLC的总裁兼首席执行官。 Granger博士此前从2011年10月起担任DLH的战略顾问委员会顾问，直至当选为董事会成员。Granger博士在美国陆军服役超过35年，并于2005年至2009年担任华盛顿特区负责国防部长（卫生事务）办公室TRICARE管理活动的副主任和项目执行官。他曾担任助理国防部长（卫生事务）的国防部健康计划，政策和绩效的首席顾问。监督了军队卫生系统内国防部管理式医疗计划的收购，运营和整合。加盟TRICARE管理活动，Granger博士领导的美国和最大的跨国战场卫生系统，同时服务于指挥官，特遣部队第44医务司令部和司令部医生为多国部队伊拉克。目前，Granger博士是The 5Ps，LLC的总裁兼首席执行官，该医疗保健，教育和领导咨询公司是在他从美国军队退休后成立的。格兰杰博士获得了阿肯色州立大学的学士学位，并获得了阿肯色大学医学院的医学学位。从阿肯色大学医学院毕业后，他被授予Henry Kaiser医疗卓越和领导力医疗奖学金。 Granger博士获得了美国医师管理学院，美国医学质量委员会，美国内科医学委员会，肿瘤内科，血液学委员会的认证，并拥有多项医学证书。公司董事的全国协会，研究员，Granger目前担任Express Scripts的控股有限公司的董事会（成员 - 遵约委员会），并还额外privately-的董事会的现任和前任顾问或成员举办公司。Granger博士还是罗莎琳德富兰克林医学和科学大学董事会成员以及阿肯色大学医学院访客委员会成员。
Elder Granger,was elected to Dlh Holdings Corp. Board of Directors in November 2014. Dr. Granger is a U.S. Army Major General (retired) and the President and Chief Executive Officer of The 5Ps LLC. Dr. Granger previously served as an advisor to DLH on its strategic advisory board from October 2011 until his election to the Board. Dr. Granger served in the U.S. Army for over 35 years and was the Deputy Director and Program Executive Officer of the TRICARE Management Activity, Office of the Assistant Secretary of Defense (Health Affairs) in Washington, D.C. from 2005 to 2009. In this role he served as the principal advisor to the Assistant Secretary of Defense (Health Affairs) on DoD health plan, policy and performance. He oversaw the acquisition, operation and integration of DoD's managed care program within the Military Health System. Prior to joining TRICARE Management Activity, Dr. Granger led the largest U.S. and multi-national battlefield health system in Dlh Holdings Corp. recent history while serving as Commander, Task Force 44th Medical Command and Command Surgeon for the Multinational Corps Iraq. Presently, Dr. Granger is the President and CEO of The 5Ps, LLC, a healthcare, education, and leadership consultancy he founded following his retirement from the U.S. Army. Dr. Granger received a B.S. Degree from Arkansas State University and earned his medical degree from University of Arkansas School of Medicine. Upon graduation from the University of Arkansas School of Medicine, he was awarded the Henry Kaiser Medical Fellowship for Medical Excellence and Leadership. Dr. Granger is board certified by the American College of Physician Executives, American Board of Medical Quality, American Board of Internal Medicine, Medical Oncology, Hematology, and holds numerous medical certifications. Additionally, Dr. Granger has earned the CERT Certificate in Cybersecurity Oversight from Carnegie Mellon University. A National Association of Corporate Director, Certified Director and Fellow, Dr. Granger currently serves on the board of directors of Cigna Corp., since December 2018 (chair – Compliance Committee and member – Corporate Governance Committee), and Better Therapeutics, Inc. since 2021 (member – Audit Committee). He served on the board of Express Scripts Holding from 2015 until its merger with Cigna Corp. and served on the board of Cerner Corp. from November 2020 to June 2022 (member – Audit Committee and Nominating, Governance and Public Policy Committee). Dr. Granger is also a current and former advisor or member of the board of directors of additional privately-held companies and also serves on the Board of Visitors of the University of Arkansas School of Medicine. - Elder Granger于2014年11月当选为董事会成员。Granger博士是退休的美国陆军少将，以及5Ps LLC的总裁兼首席执行官。 Granger博士此前从2011年10月起担任DLH的战略顾问委员会顾问，直至当选为董事会成员。Granger博士在美国陆军服役超过35年，并于2005年至2009年担任华盛顿特区负责国防部长（卫生事务）办公室TRICARE管理活动的副主任和项目执行官。他曾担任助理国防部长（卫生事务）的国防部健康计划，政策和绩效的首席顾问。监督了军队卫生系统内国防部管理式医疗计划的收购，运营和整合。加盟TRICARE管理活动，Granger博士领导的美国和最大的跨国战场卫生系统，同时服务于指挥官，特遣部队第44医务司令部和司令部医生为多国部队伊拉克。目前，Granger博士是The 5Ps，LLC的总裁兼首席执行官，该医疗保健，教育和领导咨询公司是在他从美国军队退休后成立的。格兰杰博士获得了阿肯色州立大学的学士学位，并获得了阿肯色大学医学院的医学学位。从阿肯色大学医学院毕业后，他被授予Henry Kaiser医疗卓越和领导力医疗奖学金。 Granger博士获得了美国医师管理学院，美国医学质量委员会，美国内科医学委员会，肿瘤内科，血液学委员会的认证，并拥有多项医学证书。公司董事的全国协会，研究员，Granger目前担任Express Scripts的控股有限公司的董事会（成员 - 遵约委员会），并还额外privately-的董事会的现任和前任顾问或成员举办公司。Granger博士还是罗莎琳德富兰克林医学和科学大学董事会成员以及阿肯色大学医学院访客委员会成员。
- Elder Granger,was elected to Dlh Holdings Corp. Board of Directors in November 2014. Dr. Granger is a U.S. Army Major General (retired) and the President and Chief Executive Officer of The 5Ps LLC. Dr. Granger previously served as an advisor to DLH on its strategic advisory board from October 2011 until his election to the Board. Dr. Granger served in the U.S. Army for over 35 years and was the Deputy Director and Program Executive Officer of the TRICARE Management Activity, Office of the Assistant Secretary of Defense (Health Affairs) in Washington, D.C. from 2005 to 2009. In this role he served as the principal advisor to the Assistant Secretary of Defense (Health Affairs) on DoD health plan, policy and performance. He oversaw the acquisition, operation and integration of DoD's managed care program within the Military Health System. Prior to joining TRICARE Management Activity, Dr. Granger led the largest U.S. and multi-national battlefield health system in Dlh Holdings Corp. recent history while serving as Commander, Task Force 44th Medical Command and Command Surgeon for the Multinational Corps Iraq. Presently, Dr. Granger is the President and CEO of The 5Ps, LLC, a healthcare, education, and leadership consultancy he founded following his retirement from the U.S. Army. Dr. Granger received a B.S. Degree from Arkansas State University and earned his medical degree from University of Arkansas School of Medicine. Upon graduation from the University of Arkansas School of Medicine, he was awarded the Henry Kaiser Medical Fellowship for Medical Excellence and Leadership. Dr. Granger is board certified by the American College of Physician Executives, American Board of Medical Quality, American Board of Internal Medicine, Medical Oncology, Hematology, and holds numerous medical certifications. Additionally, Dr. Granger has earned the CERT Certificate in Cybersecurity Oversight from Carnegie Mellon University. A National Association of Corporate Director, Certified Director and Fellow, Dr. Granger currently serves on the board of directors of Cigna Corp., since December 2018 (chair – Compliance Committee and member – Corporate Governance Committee), and Better Therapeutics, Inc. since 2021 (member – Audit Committee). He served on the board of Express Scripts Holding from 2015 until its merger with Cigna Corp. and served on the board of Cerner Corp. from November 2020 to June 2022 (member – Audit Committee and Nominating, Governance and Public Policy Committee). Dr. Granger is also a current and former advisor or member of the board of directors of additional privately-held companies and also serves on the Board of Visitors of the University of Arkansas School of Medicine.
- Kathleen M. Mazzarella
-
Kathleen M. Mazzarella自2013年1月起担任Graybar Electric Company, Inc.董事长。Graybar是电气，通信和数据网络产品的分销商，以及相关供应链管理和物流服务的提供商，并担任Graybar总裁兼首席执行官。自2012年6月以来。她曾于2010年12月至2012年6月担任执行副总裁兼首席运营官。Mazzarella女士于1980年1月加入Graybar，并担任越来越高的职位，包括销售和市场营销高级副总裁和高级副总裁，人力资源和战略规划。自2004年1月以来，她一直担任Graybar的董事。Mazzarella女士从2015年1月起担任圣路易斯联邦储备银行（Federal Reserve Bank of St. Louis）的董事，并从2016年4月至2019年12月担任其主席。私人公司董事会。她拥有国立路易斯大学的理学学士学位和韦伯斯特大学的工商管理硕士学位。
Kathleen M. Mazzarella,has been an independent Board member of the Company since July 2021 and served as a member of the board of Opco from January 2019 until August 2019 and Holdings from August 2019 until July 2021. Ms. Mazzarella has been the President and CEO of Graybar, an employee-owned FORTUNE 500 distributor of electrical, communications and data networking products, since 2012 and Chairman of Graybar since 2013. In addition to her role at Graybar, Ms. Mazzarella also serves as a director of Cigna Corporation and Waste Management, Inc. Ms. Mazzarella previously served as a director of Express Scripts Holding Co. and as Chairman of the Federal Reserve Bank of St. Louis. Ms. Mazzarella holds a B.A. in Behavioral Science from National Louis University and an M.B.A. from Webster University. - Kathleen M. Mazzarella自2013年1月起担任Graybar Electric Company, Inc.董事长。Graybar是电气，通信和数据网络产品的分销商，以及相关供应链管理和物流服务的提供商，并担任Graybar总裁兼首席执行官。自2012年6月以来。她曾于2010年12月至2012年6月担任执行副总裁兼首席运营官。Mazzarella女士于1980年1月加入Graybar，并担任越来越高的职位，包括销售和市场营销高级副总裁和高级副总裁，人力资源和战略规划。自2004年1月以来，她一直担任Graybar的董事。Mazzarella女士从2015年1月起担任圣路易斯联邦储备银行（Federal Reserve Bank of St. Louis）的董事，并从2016年4月至2019年12月担任其主席。私人公司董事会。她拥有国立路易斯大学的理学学士学位和韦伯斯特大学的工商管理硕士学位。
- Kathleen M. Mazzarella,has been an independent Board member of the Company since July 2021 and served as a member of the board of Opco from January 2019 until August 2019 and Holdings from August 2019 until July 2021. Ms. Mazzarella has been the President and CEO of Graybar, an employee-owned FORTUNE 500 distributor of electrical, communications and data networking products, since 2012 and Chairman of Graybar since 2013. In addition to her role at Graybar, Ms. Mazzarella also serves as a director of Cigna Corporation and Waste Management, Inc. Ms. Mazzarella previously served as a director of Express Scripts Holding Co. and as Chairman of the Federal Reserve Bank of St. Louis. Ms. Mazzarella holds a B.A. in Behavioral Science from National Louis University and an M.B.A. from Webster University.
- Mark B. McClellan
-
Mark B. McClellan于2016年1月成为Duke Robert J.Margolis，健康政策中心的首任主任和杜克大学商业、医学和政策的Margolis教授。此前，他曾在2007年至2015年担任经济研究高级研究员，并担任Brookings Institution医疗保健价值与创新倡议主任。McClellan博士在2004年至2006年期间担任美国卫生和公众服务部医疗保险和医疗补助服务中心的管理员，并在2002年至2004年期间担任美国食品和药物管理局的专员。2001年至2002年，他曾任总统经济顾问委员会成员和白宫医疗政策高级主管，1998年至2000年，他曾任财政部负责经济政策的副助理部长。McClellan博士获得德克萨斯大学文学学士学位，哈佛大学公共管理硕士和医学博士学位，麻省理工学院经济学哲学博士学位。
Mark B. Mcclellan,became the inaugural Director of the Duke-Robert J. Margolis, M.D., Center for Health Policy and the Margolis Professor of Business, Medicine and Policy at Duke University in January 2016. He currently serves in various leadership and advisory capacities for the National Academy of Medicine, the University of Texas Dell Medical School, the Institute for Clinical and Economic Review and other nonprofit organizations. He also was the founding Chair of the Reagan-Udall Foundation for the U.S. Food and Drug Administration (FDA). Dr. McClellan is a two-time recipient of the Kenneth Arrow Award for Outstanding Research in Health Economics.Previously, Dr. McClellan served from 2007 to 2015 as a Senior Fellow in Economic Studies and as Director of the Initiatives on Value and Innovation in Health Care at the Brookings Institution. He was a member of the President's Council of Economic Advisers and was White House Senior Director for Health Care Policy from 2001 to 2002. He also was the Deputy Assistant Secretary for Economic Policy for the Department of the Treasury from 1998 to 1999. Dr. McClellan served as Administrator of the Centers for Medicare & Medicaid Services for the U.S. Department of Health and Human Services from 2004 to 2006, where he oversaw implementation of the Medicare prescription drug benefit and the Medicare Advantage program. From 2002 to 2004, he served as Commissioner of the FDA, where he developed and implemented the Critical Path Initiative and other major reforms in regulatory policy.Additionally, Dr. McClellan was at the center of U.S. efforts to combat the COVID-19 pandemic and co-authored a road map detailing a comprehensive response and safe reopening. His work to respond to COVID-19 included focusing on virus containment and testing strategies; reforming health care toward more resilient models of delivering better, more equitable care and address public health challenges; accelerating the development of therapeutics and vaccines; and building a more robust global response to emerging infectious disease threats.Ph.D., Massachusetts Institute of Technology.M.D., Harvard-MIT Division of Health Sciences and Technology.MPA, Harvard University.BA, University of Texas. - Mark B. McClellan于2016年1月成为Duke Robert J.Margolis，健康政策中心的首任主任和杜克大学商业、医学和政策的Margolis教授。此前，他曾在2007年至2015年担任经济研究高级研究员，并担任Brookings Institution医疗保健价值与创新倡议主任。McClellan博士在2004年至2006年期间担任美国卫生和公众服务部医疗保险和医疗补助服务中心的管理员，并在2002年至2004年期间担任美国食品和药物管理局的专员。2001年至2002年，他曾任总统经济顾问委员会成员和白宫医疗政策高级主管，1998年至2000年，他曾任财政部负责经济政策的副助理部长。McClellan博士获得德克萨斯大学文学学士学位，哈佛大学公共管理硕士和医学博士学位，麻省理工学院经济学哲学博士学位。
- Mark B. Mcclellan,became the inaugural Director of the Duke-Robert J. Margolis, M.D., Center for Health Policy and the Margolis Professor of Business, Medicine and Policy at Duke University in January 2016. He currently serves in various leadership and advisory capacities for the National Academy of Medicine, the University of Texas Dell Medical School, the Institute for Clinical and Economic Review and other nonprofit organizations. He also was the founding Chair of the Reagan-Udall Foundation for the U.S. Food and Drug Administration (FDA). Dr. McClellan is a two-time recipient of the Kenneth Arrow Award for Outstanding Research in Health Economics.Previously, Dr. McClellan served from 2007 to 2015 as a Senior Fellow in Economic Studies and as Director of the Initiatives on Value and Innovation in Health Care at the Brookings Institution. He was a member of the President's Council of Economic Advisers and was White House Senior Director for Health Care Policy from 2001 to 2002. He also was the Deputy Assistant Secretary for Economic Policy for the Department of the Treasury from 1998 to 1999. Dr. McClellan served as Administrator of the Centers for Medicare & Medicaid Services for the U.S. Department of Health and Human Services from 2004 to 2006, where he oversaw implementation of the Medicare prescription drug benefit and the Medicare Advantage program. From 2002 to 2004, he served as Commissioner of the FDA, where he developed and implemented the Critical Path Initiative and other major reforms in regulatory policy.Additionally, Dr. McClellan was at the center of U.S. efforts to combat the COVID-19 pandemic and co-authored a road map detailing a comprehensive response and safe reopening. His work to respond to COVID-19 included focusing on virus containment and testing strategies; reforming health care toward more resilient models of delivering better, more equitable care and address public health challenges; accelerating the development of therapeutics and vaccines; and building a more robust global response to emerging infectious disease threats.Ph.D., Massachusetts Institute of Technology.M.D., Harvard-MIT Division of Health Sciences and Technology.MPA, Harvard University.BA, University of Texas.
- Kimberly A. Ross
-
Kimberly A. Ross于2020年3月至9月担任灵活空间解决方案公司WeWork（We Company）的首席财务官。她曾担任能源技术公司Baker Hughes Company的高级副总裁兼首席财务官，2014年9月至2017年7月，Ross女士于2011年11月至2014年9月担任雅芳产品有限公司执行副总裁兼首席财务官，雅芳产品有限公司是一家全球美容及相关产品制造商和销售商。在加入雅芳之前，2007年至2011年，Ross女士担任食品零售公司Royal Ahold N.V。的执行副总裁兼首席财务官。在此之前，Ross女士曾在Ahold担任多个高级管理职位。罗斯女士获得南佛罗里达州大学文科学士学位。
Kimberly A. Ross,served as Chief Financial Officer of WeWork (the We Company), a flexible space solutions company, from March through September 2020. She served as Senior Vice President and Chief Financial Officer of Baker Hughes Company, an energy technology company, from September 2014 to July 2017.Additionally, Ms. Ross was Executive Vice President and Chief Financial Officer of Avon Products, Inc., a global manufacturer and marketer of beauty and related products, from November 2011 until September 2014. Prior to joining Avon, she served as the Executive Vice President and Chief Financial Officer of Royal Ahold N.V. (Royal Ahold), a food retail company, from 2007 to 2011, and held a variety of senior management positions during her tenure, which began in 2001. She has expertise in corporate finance, financial planning and analysis, strategy, mergers and acquisitions, corporate restructuring, financial reporting, and internal auditing processes as well as IT operations oversight, and she holds a Cybersecurity Certification from the NACD.Ms. Ross is an active member of her alma mater, sitting on the Foundation Board of the University of South Florida and the Advisory Board of the Muma College of Business.BA, University of South Florida. - Kimberly A. Ross于2020年3月至9月担任灵活空间解决方案公司WeWork（We Company）的首席财务官。她曾担任能源技术公司Baker Hughes Company的高级副总裁兼首席财务官，2014年9月至2017年7月，Ross女士于2011年11月至2014年9月担任雅芳产品有限公司执行副总裁兼首席财务官，雅芳产品有限公司是一家全球美容及相关产品制造商和销售商。在加入雅芳之前，2007年至2011年，Ross女士担任食品零售公司Royal Ahold N.V。的执行副总裁兼首席财务官。在此之前，Ross女士曾在Ahold担任多个高级管理职位。罗斯女士获得南佛罗里达州大学文科学士学位。
- Kimberly A. Ross,served as Chief Financial Officer of WeWork (the We Company), a flexible space solutions company, from March through September 2020. She served as Senior Vice President and Chief Financial Officer of Baker Hughes Company, an energy technology company, from September 2014 to July 2017.Additionally, Ms. Ross was Executive Vice President and Chief Financial Officer of Avon Products, Inc., a global manufacturer and marketer of beauty and related products, from November 2011 until September 2014. Prior to joining Avon, she served as the Executive Vice President and Chief Financial Officer of Royal Ahold N.V. (Royal Ahold), a food retail company, from 2007 to 2011, and held a variety of senior management positions during her tenure, which began in 2001. She has expertise in corporate finance, financial planning and analysis, strategy, mergers and acquisitions, corporate restructuring, financial reporting, and internal auditing processes as well as IT operations oversight, and she holds a Cybersecurity Certification from the NACD.Ms. Ross is an active member of her alma mater, sitting on the Foundation Board of the University of South Florida and the Advisory Board of the Muma College of Business.BA, University of South Florida.
- Neesha Hathi
-
Neesha Hathi 自 2017 年起担任金融服务公司 The Charles Schwab Corporation Charles Schwab 的首席数字官。在 2016 年至 2017 年期间，她还在 Charles Schwab 担任投资者服务平台、战略和客户体验执行副总裁； 顾问服务高级副总裁； 2012 年至 2016 年担任 Schwab Performance Technologies 首席运营官； 顾问技术解决方案副总裁； 2009 年至 2012 年担任 Schwab Performance Technologies 首席运营官； 2007年至2009年战略副总裁； 2004 年至 2007 年战略总监； 2004 年担任部门管理高级经理。Hathi 女士获得了密歇根大学的理学学士学位和加利福尼亚大学的工商管理硕士学位。
Neesha Hathi,has served as Head of Wealth and Advice Solutions of The Charles Schwab Corporation (Charles Schwab), a financial services company, since 2022. Over the course of her 18-year career with Charles Schwab, Ms. Hathi has held positions of increasing responsibility. Notably, she was Chief Digital Officer from 2017 to 2022, during which time she was responsible for digital transformation, business innovation, and data and analytics. Prior to that role, she served as Executive Vice President of Investor Services Platforms, Strategy and Client Experience from 2016 to 2017, as Senior Vice President of Advisor Services and Chief Operating Officer of Schwab Performance Technologies from 2012 through 2016.Ms. Hathi serves on the Advisory Board of the Morrison Center for Marketing & Data Analytics at the University of California, Los Angeles, as well as The Charles Schwab Foundation.MBA, University of California.BS, University of Michigan. - Neesha Hathi 自 2017 年起担任金融服务公司 The Charles Schwab Corporation Charles Schwab 的首席数字官。在 2016 年至 2017 年期间，她还在 Charles Schwab 担任投资者服务平台、战略和客户体验执行副总裁； 顾问服务高级副总裁； 2012 年至 2016 年担任 Schwab Performance Technologies 首席运营官； 顾问技术解决方案副总裁； 2009 年至 2012 年担任 Schwab Performance Technologies 首席运营官； 2007年至2009年战略副总裁； 2004 年至 2007 年战略总监； 2004 年担任部门管理高级经理。Hathi 女士获得了密歇根大学的理学学士学位和加利福尼亚大学的工商管理硕士学位。
- Neesha Hathi,has served as Head of Wealth and Advice Solutions of The Charles Schwab Corporation (Charles Schwab), a financial services company, since 2022. Over the course of her 18-year career with Charles Schwab, Ms. Hathi has held positions of increasing responsibility. Notably, she was Chief Digital Officer from 2017 to 2022, during which time she was responsible for digital transformation, business innovation, and data and analytics. Prior to that role, she served as Executive Vice President of Investor Services Platforms, Strategy and Client Experience from 2016 to 2017, as Senior Vice President of Advisor Services and Chief Operating Officer of Schwab Performance Technologies from 2012 through 2016.Ms. Hathi serves on the Advisory Board of the Morrison Center for Marketing & Data Analytics at the University of California, Los Angeles, as well as The Charles Schwab Foundation.MBA, University of California.BS, University of Michigan.
- Philip Ozuah
-
Philip Ozuah 是 Montefiore Medicine 的总裁兼首席执行官，Montefiore Medicine公司是 Montefiore 卫生系统和阿尔伯特爱因斯坦医学院的伞式组织，此前曾于 2018 年至 2019 年担任总裁，并于 2012 年至 2018 年担任执行副总裁兼首席运营官蒙蒂菲奥里卫生系统。 2005 年至 2014 年期间，Ozuah 博士担任儿科系主任，自 1992 年以来一直担任阿尔伯特爱因斯坦医学院儿科、流行病学和人口健康系的教授。 Ozuah 博士获得了尼日利亚伊巴丹大学的医学博士学位、南加州大学的硕士学位和博士学位。来自内布拉斯加大学。他在阿尔伯特爱因斯坦医学院和蒙蒂菲奥里完成了儿科实习和住院医师实习，并在南加州大学医学院完成了医学教育博士后奖学金。 Ozuah 博士是 Montefiore 医院、纽约市警察基金会和联邦执法基金会的董事会成员。
Philip Ozuah,is the President and Chief Executive Officer of Montefiore Medicine, the umbrella organization for the Montefiore Health System and Albert Einstein College of Medicine, having previously served as the President from 2018 to 2019 and Executive Vice President and Chief Operating Officer from 2012 to 2018 of Montefiore Health System. Between 2005 and 2014, Dr. Ozuah was Chairman of the Department of Pediatrics and has been a Professor in the Departments of Pediatrics and Epidemiology and Population Health since 1992 at Albert Einstein College of Medicine. Dr. Ozuah received his M.D. from the University of Ibadan, Nigeria, his master's degree from the University of Southern California, and his Ph.D. from the University of Nebraska. He completed his Pediatric Internship and Residency at Albert Einstein College of Medicine and Montefiore, and his Post-Doctoral Fellowship in Medical Education at the University of Southern California School of Medicine. Dr. Ozuah is on the board of Montefiore Hospital, as well as the NYC Police Foundation and Federal Law Enforcement Foundation. - Philip Ozuah 是 Montefiore Medicine 的总裁兼首席执行官，Montefiore Medicine公司是 Montefiore 卫生系统和阿尔伯特爱因斯坦医学院的伞式组织，此前曾于 2018 年至 2019 年担任总裁，并于 2012 年至 2018 年担任执行副总裁兼首席运营官蒙蒂菲奥里卫生系统。 2005 年至 2014 年期间，Ozuah 博士担任儿科系主任，自 1992 年以来一直担任阿尔伯特爱因斯坦医学院儿科、流行病学和人口健康系的教授。 Ozuah 博士获得了尼日利亚伊巴丹大学的医学博士学位、南加州大学的硕士学位和博士学位。来自内布拉斯加大学。他在阿尔伯特爱因斯坦医学院和蒙蒂菲奥里完成了儿科实习和住院医师实习，并在南加州大学医学院完成了医学教育博士后奖学金。 Ozuah 博士是 Montefiore 医院、纽约市警察基金会和联邦执法基金会的董事会成员。
- Philip Ozuah,is the President and Chief Executive Officer of Montefiore Medicine, the umbrella organization for the Montefiore Health System and Albert Einstein College of Medicine, having previously served as the President from 2018 to 2019 and Executive Vice President and Chief Operating Officer from 2012 to 2018 of Montefiore Health System. Between 2005 and 2014, Dr. Ozuah was Chairman of the Department of Pediatrics and has been a Professor in the Departments of Pediatrics and Epidemiology and Population Health since 1992 at Albert Einstein College of Medicine. Dr. Ozuah received his M.D. from the University of Ibadan, Nigeria, his master's degree from the University of Southern California, and his Ph.D. from the University of Nebraska. He completed his Pediatric Internship and Residency at Albert Einstein College of Medicine and Montefiore, and his Post-Doctoral Fellowship in Medical Education at the University of Southern California School of Medicine. Dr. Ozuah is on the board of Montefiore Hospital, as well as the NYC Police Foundation and Federal Law Enforcement Foundation.
- Eric C. Wiseman
-
Eric C. Wiseman，2006年3月任V.F。公司（服装公司）总裁；2008年1月任首席执行官；2008年8月任该公司董事长。此前，2006年3月至2008年1月任V.F。公司首席运营官。他1995年加入V.F。公司，公司任期内担任许多领导职位，包括全球品牌行政副总裁、运动服户外联盟董事长及副总裁。他目前任职于CIGNA公司董事会。他同时也是零售业领导协会（Retail Industry Leaders Association）财务主管和理事会成员，维克森林大学（Wake Forest University ）商学院主席和理事会成员。
Eric C. Wiseman,has served as The Cigna Group's Lead Independent Director since January 2022. He was Executive Chair of VF Corporation, an apparel and footwear company, from August 2008 until October 2017. He served as VF Corporation's Chief Executive Officer from January 2008 until December 2016, President from 2006 until June 2015 and Chief Operating Officer from 2006 to 2008. Prior to that, Mr. Wiseman held a variety of senior management positions at the company.Mr. Wiseman is an active member of his community, and he also sits on the Board of Trustees for Wake Forest University and the Board of Visitors for the Wake Forest School of Business. He also served on the American Heart Association CEO Roundtable, a leadership collaborative of CEOs exclusively dedicated to improving employee and community health.BS and MBA, Wake Forest University. - Eric C. Wiseman，2006年3月任V.F。公司（服装公司）总裁；2008年1月任首席执行官；2008年8月任该公司董事长。此前，2006年3月至2008年1月任V.F。公司首席运营官。他1995年加入V.F。公司，公司任期内担任许多领导职位，包括全球品牌行政副总裁、运动服户外联盟董事长及副总裁。他目前任职于CIGNA公司董事会。他同时也是零售业领导协会（Retail Industry Leaders Association）财务主管和理事会成员，维克森林大学（Wake Forest University ）商学院主席和理事会成员。
- Eric C. Wiseman,has served as The Cigna Group's Lead Independent Director since January 2022. He was Executive Chair of VF Corporation, an apparel and footwear company, from August 2008 until October 2017. He served as VF Corporation's Chief Executive Officer from January 2008 until December 2016, President from 2006 until June 2015 and Chief Operating Officer from 2006 to 2008. Prior to that, Mr. Wiseman held a variety of senior management positions at the company.Mr. Wiseman is an active member of his community, and he also sits on the Board of Trustees for Wake Forest University and the Board of Visitors for the Wake Forest School of Business. He also served on the American Heart Association CEO Roundtable, a leadership collaborative of CEOs exclusively dedicated to improving employee and community health.BS and MBA, Wake Forest University.
- Donna F. Zarcone
-
Donna F. Zarcone，2012年2月任芝加哥经济俱乐部（Economic Club of Chicago，公民和企业领导组织）总裁及首席执行官。她于2011年10月至2012年2月担任芝加哥经济俱乐部临时总裁；2007年至2012年2月担任D. F. Zarcone & Associates LLC公司（战略顾问公司）总裁及首席执行官；1998年至2006年担任Harley-Davidson金融服务公司（批发、零售金融、保险、信用卡业务的供应商，Harley-Davidson公司的独资子公司）总裁及首席运营官；2011年担任CDW 公司（科技产品及服务供应商）董事；2007年至2012年担任The Jones Group公司（品牌衣服的设计、销售、批发商）董事；2002年至2006年任Eaglemark储蓄银行董事长。她被美国国家公司董事协会授予2012年100名美国董事之一的资格。她目前在Cigna公司任期为2013年至2016年。
Donna F. Zarcone,served as the President and Chief Executive Officer of The Economic Club of Chicago from February 2012 until July 2020, as well as Interim President from October 2011 until February 2012. She was President and Chief Executive Officer of D.F. Zarcone & Associates LLC, a strategic advisory firm, from 2007 until February 2012. Ms. Zarcone served as the President and Chief Operating Officer of Harley-Davidson Financial Services, Inc. (HDFS). She also led the formation of Eaglemark Savings Bank, a wholly owned subsidiary of HDFS, and served as its Chair and President. Early in her career, she served as the Chief Financial Officer for two start-ups, a technology leasing firm and a financial technology company, that were subsequently sold to strategic investors.Ms. Zarcone has been serving on corporate boards for more than 30 years and is an Audit Committee Financial Expert and a certified public accountant. She is an NACD-Certified Director and is credentialed in Environmental, Social and Governance (ESG) and climate governance by NACD. She was also recently invited to serve as a NACD Commissioner for the Future of the American Board Initiative to re-examine the role of the board beyond its ongoing commitment to shareholders. In 2022, she was featured in NACD's Directorship magazine, which highlighted her commitment to director professionalism. She also holds a Certificate in Cybersecurity Oversight from Carnegie Mellon University.Ms. Zarcone is the Chair of the Investment Committee for the Duchossois Group and serves as Chair of the Audit Committee for Quinnox. She also serves on the National Board of the Smithsonian Institution with a focus on sustainability and digital transformation through the organization's 'Our Shared Future' initiatives. - Donna F. Zarcone，2012年2月任芝加哥经济俱乐部（Economic Club of Chicago，公民和企业领导组织）总裁及首席执行官。她于2011年10月至2012年2月担任芝加哥经济俱乐部临时总裁；2007年至2012年2月担任D. F. Zarcone & Associates LLC公司（战略顾问公司）总裁及首席执行官；1998年至2006年担任Harley-Davidson金融服务公司（批发、零售金融、保险、信用卡业务的供应商，Harley-Davidson公司的独资子公司）总裁及首席运营官；2011年担任CDW 公司（科技产品及服务供应商）董事；2007年至2012年担任The Jones Group公司（品牌衣服的设计、销售、批发商）董事；2002年至2006年任Eaglemark储蓄银行董事长。她被美国国家公司董事协会授予2012年100名美国董事之一的资格。她目前在Cigna公司任期为2013年至2016年。
- Donna F. Zarcone,served as the President and Chief Executive Officer of The Economic Club of Chicago from February 2012 until July 2020, as well as Interim President from October 2011 until February 2012. She was President and Chief Executive Officer of D.F. Zarcone & Associates LLC, a strategic advisory firm, from 2007 until February 2012. Ms. Zarcone served as the President and Chief Operating Officer of Harley-Davidson Financial Services, Inc. (HDFS). She also led the formation of Eaglemark Savings Bank, a wholly owned subsidiary of HDFS, and served as its Chair and President. Early in her career, she served as the Chief Financial Officer for two start-ups, a technology leasing firm and a financial technology company, that were subsequently sold to strategic investors.Ms. Zarcone has been serving on corporate boards for more than 30 years and is an Audit Committee Financial Expert and a certified public accountant. She is an NACD-Certified Director and is credentialed in Environmental, Social and Governance (ESG) and climate governance by NACD. She was also recently invited to serve as a NACD Commissioner for the Future of the American Board Initiative to re-examine the role of the board beyond its ongoing commitment to shareholders. In 2022, she was featured in NACD's Directorship magazine, which highlighted her commitment to director professionalism. She also holds a Certificate in Cybersecurity Oversight from Carnegie Mellon University.Ms. Zarcone is the Chair of the Investment Committee for the Duchossois Group and serves as Chair of the Audit Committee for Quinnox. She also serves on the National Board of the Smithsonian Institution with a focus on sustainability and digital transformation through the organization's 'Our Shared Future' initiatives.
- Eric J. Foss
-
Eric J. Foss，2012年5月任ARAMARK公司（公开上市的餐饮服务、设施管理、制服及职业装供应商）总裁、首席执行官、董事。他2010年至2011年12月担任百事饮料公司首席执行官；2008年至2010年任百事瓶装集团（Pepsi Bottling Group）董事长和首席执行官；2006年至2008年任总裁及首席执行官。他2003年就职于UDR公司（房地产投资信托公司）董事会。他目前在Cigna公司任期为2011年至2014年。
Eric J. Foss,served as President and Chief Executive Officer of Aramark, a provider of food services, facilities management and uniform services, starting in May 2012. He also served as Aramark Chair of the Board starting in February 2015 until his retirement in August 2019. He served as Chief Executive Officer of Pepsi Beverages Company, a beverage manufacturer, seller and distributor and a division of PepsiCo, Inc., from 2010 until December 2011. He was the Chair and Chief Executive Officer of The Pepsi Bottling Group, Inc., from 2008 until 2010, President and Chief Executive Officer from 2006 until 2008, and Chief Operating Officer from 2005 until 2006.Mr. Foss also serves on the National Board of Directors for the Back on My Feet Foundation.BS, Ball State University. - Eric J. Foss，2012年5月任ARAMARK公司（公开上市的餐饮服务、设施管理、制服及职业装供应商）总裁、首席执行官、董事。他2010年至2011年12月担任百事饮料公司首席执行官；2008年至2010年任百事瓶装集团（Pepsi Bottling Group）董事长和首席执行官；2006年至2008年任总裁及首席执行官。他2003年就职于UDR公司（房地产投资信托公司）董事会。他目前在Cigna公司任期为2011年至2014年。
- Eric J. Foss,served as President and Chief Executive Officer of Aramark, a provider of food services, facilities management and uniform services, starting in May 2012. He also served as Aramark Chair of the Board starting in February 2015 until his retirement in August 2019. He served as Chief Executive Officer of Pepsi Beverages Company, a beverage manufacturer, seller and distributor and a division of PepsiCo, Inc., from 2010 until December 2011. He was the Chair and Chief Executive Officer of The Pepsi Bottling Group, Inc., from 2008 until 2010, President and Chief Executive Officer from 2006 until 2008, and Chief Operating Officer from 2005 until 2006.Mr. Foss also serves on the National Board of Directors for the Back on My Feet Foundation.BS, Ball State University.
- William J. DeLaney
-
William J. DeLaney， 2011年9月被任命为快捷药方公司董事，自2009年3月起任西斯科公司（食品营销和分销公司）首席执行官，一直到现在。2010年3月担任西斯科公司总裁。1987年他开始在西斯科任职，并担任各种不同职位。2007年7月他成为西斯科公司行政副总裁和首席财务官，直到2009年10月才退下。自2009年1月他就是西斯科公司的董事会成员。 DeLaney先生于2009年至2017年担任Sysco的董事。他获得了圣母大学的学士学位和宾夕法尼亚大学沃顿商学院研究生院的工商管理硕士学位。
William J. Delaney,served as Chief Executive Officer of Sysco Corporation (Sysco), a food marketing and distribution company, from March 2009 until his retirement in December 2017. Previously, Mr. DeLaney served as President of Sysco from March 2010 to January 2016, served as Executive Vice President and Chief Financial Officer from July 2007 to October 2009, and held multiple corporate and operating positions of increasing responsibility throughout his 29-year career with Sysco.In addition to his corporate work, Mr. DeLaney previously served as an active member of his community through his involvement with the Center for Houston's Future and the Greater Houston Partnership.MBA, University of Pennsylvania,Wharton Graduate Division.BBA, University of Notre Dame. - William J. DeLaney， 2011年9月被任命为快捷药方公司董事，自2009年3月起任西斯科公司（食品营销和分销公司）首席执行官，一直到现在。2010年3月担任西斯科公司总裁。1987年他开始在西斯科任职，并担任各种不同职位。2007年7月他成为西斯科公司行政副总裁和首席财务官，直到2009年10月才退下。自2009年1月他就是西斯科公司的董事会成员。 DeLaney先生于2009年至2017年担任Sysco的董事。他获得了圣母大学的学士学位和宾夕法尼亚大学沃顿商学院研究生院的工商管理硕士学位。
- William J. Delaney,served as Chief Executive Officer of Sysco Corporation (Sysco), a food marketing and distribution company, from March 2009 until his retirement in December 2017. Previously, Mr. DeLaney served as President of Sysco from March 2010 to January 2016, served as Executive Vice President and Chief Financial Officer from July 2007 to October 2009, and held multiple corporate and operating positions of increasing responsibility throughout his 29-year career with Sysco.In addition to his corporate work, Mr. DeLaney previously served as an active member of his community through his involvement with the Center for Houston's Future and the Greater Houston Partnership.MBA, University of Pennsylvania,Wharton Graduate Division.BBA, University of Notre Dame.
- George Kurian
-
George Kurian于2015年6月1日被任命为首席执行官。他于2015年6月加入Netapp, Inc.董事会。从2013年9月到2015年5月，他担任产品运营的执行副总裁，监督Netapp, Inc.产品组合的技术战略、产品和解决方案开发的所有方面。Kurian先生于2011年4月加入NetApp，担任存储解决方案集团的高级副总裁，并于2011年12月被任命为数据ONTAP集团的高级副总裁。加入NetApp之前，从2002年到2011年，他在Cisco Systems担任多个职位，包括最近的应用网络和交换技术集团的副总裁和总经理。1999年至2002年，Kurian先生担任Akamai Technologies的产品管理和战略副总裁。在此之前，他是McKinsey and Company的管理顾问，并领导Oracle Corporation的软件工程和产品管理团队。他是全球健康服务公司Cigna Corporation的董事会成员。Kurian先生持有Princeton University的电气工程学士学位和Stanford University的工商管理硕士学位。
George Kurian,was appointed Chief Executive Officer of NetApp, and has served as a member of the Board, since 2015. From 2013 to 2015, he was executive vice president of product operations, overseeing all aspects of technology strategy and product and solutions development across Netapp, Inc. product portfolio. Mr. Kurian joined NetApp in April 2011 as the senior vice president of the storage solutions group and was appointed to senior vice president of the Data ONTAP group in December 2011. Prior to NetApp, from 2002 to 2011, Mr. Kurian held several positions at Cisco Systems, including most recently as vice president and general manager of the application networking and switching technology group. From 1999 to 2002, Mr. Kurian was the vice president of product management and strategy at Akamai Technologies. Prior to that, he was a management consultant with McKinsey & Company, and led software engineering and product management teams at Oracle Corporation. Mr. Kurian is a board member at Cigna Corporation, a global health services company.Princeton University (B.S., Electrical Engineering);Stanford University (M.B.A.). - George Kurian于2015年6月1日被任命为首席执行官。他于2015年6月加入Netapp, Inc.董事会。从2013年9月到2015年5月，他担任产品运营的执行副总裁，监督Netapp, Inc.产品组合的技术战略、产品和解决方案开发的所有方面。Kurian先生于2011年4月加入NetApp，担任存储解决方案集团的高级副总裁，并于2011年12月被任命为数据ONTAP集团的高级副总裁。加入NetApp之前，从2002年到2011年，他在Cisco Systems担任多个职位，包括最近的应用网络和交换技术集团的副总裁和总经理。1999年至2002年，Kurian先生担任Akamai Technologies的产品管理和战略副总裁。在此之前，他是McKinsey and Company的管理顾问，并领导Oracle Corporation的软件工程和产品管理团队。他是全球健康服务公司Cigna Corporation的董事会成员。Kurian先生持有Princeton University的电气工程学士学位和Stanford University的工商管理硕士学位。
- George Kurian,was appointed Chief Executive Officer of NetApp, and has served as a member of the Board, since 2015. From 2013 to 2015, he was executive vice president of product operations, overseeing all aspects of technology strategy and product and solutions development across Netapp, Inc. product portfolio. Mr. Kurian joined NetApp in April 2011 as the senior vice president of the storage solutions group and was appointed to senior vice president of the Data ONTAP group in December 2011. Prior to NetApp, from 2002 to 2011, Mr. Kurian held several positions at Cisco Systems, including most recently as vice president and general manager of the application networking and switching technology group. From 1999 to 2002, Mr. Kurian was the vice president of product management and strategy at Akamai Technologies. Prior to that, he was a management consultant with McKinsey & Company, and led software engineering and product management teams at Oracle Corporation. Mr. Kurian is a board member at Cigna Corporation, a global health services company.Princeton University (B.S., Electrical Engineering);Stanford University (M.B.A.).
高管简历
中英对照 | 中文 | 英文- David M. Cordani
David M. Cordani，2008年6月任公司总裁，2009年12月任首席执行官。2008年6月至2009年12月任首席运营官；2005年至2008年任Cigna HealthCare公司总裁；2004年至2005年任Cigna HealthCare公司客户及营销部门高级副总裁；1991年加入Cigna公司。他现任董事任期为2013年至2016年。
David M. Cordani,Chairman of the Board of The Cigna Group beginning January 2022; Chief Executive Officer beginning December 2009; Director since October 2009; President beginning June 2008; and Chief Operating Officer from June 2008 until December 2009.- David M. Cordani，2008年6月任公司总裁，2009年12月任首席执行官。2008年6月至2009年12月任首席运营官；2005年至2008年任Cigna HealthCare公司总裁；2004年至2005年任Cigna HealthCare公司客户及营销部门高级副总裁；1991年加入Cigna公司。他现任董事任期为2013年至2016年。
- David M. Cordani,Chairman of the Board of The Cigna Group beginning January 2022; Chief Executive Officer beginning December 2009; Director since October 2009; President beginning June 2008; and Chief Operating Officer from June 2008 until December 2009.
- Michael Triplett
Michael Triplett，曾担任美国市场总裁（始于2017年2月），区域部门领导（从2009年6月至2017年2月）。
Michael Triplett,Special Advisor beginning January 2024; President, U.S. Commercial of Cigna Healthcare beginning February 2017 to January 2024; and Regional Segment Lead from June 2009 to February 2017.- Michael Triplett，曾担任美国市场总裁（始于2017年2月），区域部门领导（从2009年6月至2017年2月）。
- Michael Triplett,Special Advisor beginning January 2024; President, U.S. Commercial of Cigna Healthcare beginning February 2017 to January 2024; and Regional Segment Lead from June 2009 to February 2017.
- Brian C. Evanko
Brian C. Evanko，政府业务总裁，2017年11月开始； 2013年8月至2017年11月为美国个人业务总裁； 2012年9月至2013年8月，信诺全球个人健康，生命和事故业务财务总监； 2008年12月至2012年9月，信诺全球，健康，生命和事故个人首席精算师。
Brian C. Evanko,Executive Vice President, Chief Financial Officer of The Cigna Group and President and Chief Executive Officer, Cigna Healthcare beginning January 2024; Executive Vice President and Chief Financial Officer of The Cigna Group from January 2021 to January 2024; President, Government Business from November 2017 to January 2021; and President, U.S. Individual Business from August 2013 to November 2017.- Brian C. Evanko，政府业务总裁，2017年11月开始； 2013年8月至2017年11月为美国个人业务总裁； 2012年9月至2013年8月，信诺全球个人健康，生命和事故业务财务总监； 2008年12月至2012年9月，信诺全球，健康，生命和事故个人首席精算师。
- Brian C. Evanko,Executive Vice President, Chief Financial Officer of The Cigna Group and President and Chief Executive Officer, Cigna Healthcare beginning January 2024; Executive Vice President and Chief Financial Officer of The Cigna Group from January 2021 to January 2024; President, Government Business from November 2017 to January 2021; and President, U.S. Individual Business from August 2013 to November 2017.
- Eric P. Palmer
Eric P. Palmer，执行副总裁兼首席财务官，自2017年6月开始； 2017年2月至2017年6月为副首席财务官； 2015年11月至2017年2月，担任高级副总裁，首席商务财务官； 2012年4月至2015年11月，担任医疗保健业务财务副总裁。并于2010年6月至2012年4月担任美国商业市场业务财务副总裁兼副总裁。
Eric P. Palmer,Executive Vice President, Enterprise Strategy of The Cigna Group and President and Chief Executive Officer, Evernorth Health Services beginning January 2024; President and Chief Executive Officer of Evernorth Health Services beginning January 2022 to January 2024; President and Chief Operating Officer from January 2021 until December 2021; Executive Vice President and Chief Financial Officer of The Cigna Group from June 2017 to January 2021; Deputy Chief Financial Officer from February 2017 until June 2017; Senior Vice President, Chief Business Financial Officer from November 2015 to February 2017; and Vice President, Business Financial Officer, Health Care from April 2012 to November 2015.- Eric P. Palmer，执行副总裁兼首席财务官，自2017年6月开始； 2017年2月至2017年6月为副首席财务官； 2015年11月至2017年2月，担任高级副总裁，首席商务财务官； 2012年4月至2015年11月，担任医疗保健业务财务副总裁。并于2010年6月至2012年4月担任美国商业市场业务财务副总裁兼副总裁。
- Eric P. Palmer,Executive Vice President, Enterprise Strategy of The Cigna Group and President and Chief Executive Officer, Evernorth Health Services beginning January 2024; President and Chief Executive Officer of Evernorth Health Services beginning January 2022 to January 2024; President and Chief Operating Officer from January 2021 until December 2021; Executive Vice President and Chief Financial Officer of The Cigna Group from June 2017 to January 2021; Deputy Chief Financial Officer from February 2017 until June 2017; Senior Vice President, Chief Business Financial Officer from November 2015 to February 2017; and Vice President, Business Financial Officer, Health Care from April 2012 to November 2015.
- Noelle K. Eder
Noelle K. Eder，她担任CIGNA Corporation的执行副总裁兼首席信息官。从2018年3月到2020年9月，Eder女士担任Hilton Worldwide Holdings Inc.的执行副总裁兼首席信息和数字官。从2016年11月到2018年3月，Eder女士担任Capital One Financial Corporation的首席卡客户体验官，从2014年9月到2016年11月，Eder女士担任Capital One Financial Corporation的卡客户体验执行副总裁。从2013年5月到2014年8月，她担任Intuit Inc.的多种职务，包括高级副总裁兼首席客户服务官。
Noelle K. Eder,Executive Vice President, Global Chief Information Officer of The Cigna Group beginning September 2020, with responsibility for the Company's technology and operations function beginning September 2023; Executive Vice President, Chief Information and Digital Officer at Hilton Worldwide Holdings from March 2018 until August 2020; Executive Vice President, Chief Card Customer Experience Officer at Capital One Financial Corporation from November 2016 until 2018; and Executive Vice President, Customer Experience and Operations at Capital One Financial Corporation from September 2014 until November 2016.- Noelle K. Eder，她担任CIGNA Corporation的执行副总裁兼首席信息官。从2018年3月到2020年9月，Eder女士担任Hilton Worldwide Holdings Inc.的执行副总裁兼首席信息和数字官。从2016年11月到2018年3月，Eder女士担任Capital One Financial Corporation的首席卡客户体验官，从2014年9月到2016年11月，Eder女士担任Capital One Financial Corporation的卡客户体验执行副总裁。从2013年5月到2014年8月，她担任Intuit Inc.的多种职务，包括高级副总裁兼首席客户服务官。
- Noelle K. Eder,Executive Vice President, Global Chief Information Officer of The Cigna Group beginning September 2020, with responsibility for the Company's technology and operations function beginning September 2023; Executive Vice President, Chief Information and Digital Officer at Hilton Worldwide Holdings from March 2018 until August 2020; Executive Vice President, Chief Card Customer Experience Officer at Capital One Financial Corporation from November 2016 until 2018; and Executive Vice President, Customer Experience and Operations at Capital One Financial Corporation from September 2014 until November 2016.
- David Brailer
David Brailer，自2022年9月起担任The Cigna Group执行副总裁兼首席健康官；自2011年起担任Health Evolution Founder兼董事长。
David Brailer,Executive Vice President and Chief Health Officer of The Cigna Group beginning September 2022; and Founder and Chairman of Health Evolution beginning in 2011.- David Brailer，自2022年9月起担任The Cigna Group执行副总裁兼首席健康官；自2011年起担任Health Evolution Founder兼董事长。
- David Brailer,Executive Vice President and Chief Health Officer of The Cigna Group beginning September 2022; and Founder and Chairman of Health Evolution beginning in 2011.
- Mary T. Agoglia Hoeltzel
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Nicole S. Jones
Nicole S. Jones，2011年6月任Cigna公司执行副总裁及法律总顾问；2010年5月至2011年6月任林肯金融集团（Lincoln Financial Group）高级副总裁及法律总顾问；2008年4月至2010年5月任Cigna公司副总裁及代理法律总顾问；2006年9月至2010年4月任Cigna公司董事会秘书。
Nicole S. Jones,Executive Vice President, Chief Administrative Officer, and General Counsel for The Cigna Group beginning September 2023; Executive Vice President and General Counsel of The Cigna Group beginning June 2011 to September 2023; Senior Vice President and General Counsel of Lincoln Financial Group from May 2010 until June 2011; Vice President and Deputy General Counsel of The Cigna Group from April 2008 until May 2010; and Corporate Secretary from September 2006 until April 2010.- Nicole S. Jones，2011年6月任Cigna公司执行副总裁及法律总顾问；2010年5月至2011年6月任林肯金融集团（Lincoln Financial Group）高级副总裁及法律总顾问；2008年4月至2010年5月任Cigna公司副总裁及代理法律总顾问；2006年9月至2010年4月任Cigna公司董事会秘书。
- Nicole S. Jones,Executive Vice President, Chief Administrative Officer, and General Counsel for The Cigna Group beginning September 2023; Executive Vice President and General Counsel of The Cigna Group beginning June 2011 to September 2023; Senior Vice President and General Counsel of Lincoln Financial Group from May 2010 until June 2011; Vice President and Deputy General Counsel of The Cigna Group from April 2008 until May 2010; and Corporate Secretary from September 2006 until April 2010.